Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn's Disease.
Crohns Colitis 360
; 4(4): otac048, 2022 Oct.
Article
em En
| MEDLINE
| ID: mdl-36778514
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article